The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Atrial Fibrillation Devices Market Research Report 2024

Global Atrial Fibrillation Devices Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1411207

No of Pages : 105

Ask Your Query
Synopsis
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF.
The global Atrial Fibrillation Devices market was valued at US$ 2902 million in 2023 and is anticipated to reach US$ 5972 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
The leading manufacturers of atrial fibrillation devices include Abbott, Boston Scientific, Biosense Webster, etc, with the top 2 accounting for about 60%.
North America is the largest market with about 37%, followed by Europe with about 27%.In terms of product, catheter ablation is the largest segment, with a share over 88%. And in terms of application, the largest application is ambulatory surgical centers, followed by hospitals.
This report aims to provide a comprehensive presentation of the global market for Atrial Fibrillation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrial Fibrillation Devices.
Report Scope
The Atrial Fibrillation Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atrial Fibrillation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atrial Fibrillation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical
Johnson & Johnson
Segment by Type
Catheter Ablation
Maze Surgery
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atrial Fibrillation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atrial Fibrillation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Atrial Fibrillation Devices Market Overview
1.1 Product Overview and Scope of Atrial Fibrillation Devices
1.2 Atrial Fibrillation Devices Segment by Type
1.2.1 Global Atrial Fibrillation Devices Market Value Comparison by Type (2024-2030)
1.2.2 Catheter Ablation
1.2.3 Maze Surgery
1.3 Atrial Fibrillation Devices Segment by Application
1.3.1 Global Atrial Fibrillation Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Atrial Fibrillation Devices Market Size Estimates and Forecasts
1.4.1 Global Atrial Fibrillation Devices Revenue 2019-2030
1.4.2 Global Atrial Fibrillation Devices Sales 2019-2030
1.4.3 Global Atrial Fibrillation Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atrial Fibrillation Devices Market Competition by Manufacturers
2.1 Global Atrial Fibrillation Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atrial Fibrillation Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atrial Fibrillation Devices Average Price by Manufacturers (2019-2024)
2.4 Global Atrial Fibrillation Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atrial Fibrillation Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atrial Fibrillation Devices, Product Type & Application
2.7 Atrial Fibrillation Devices Market Competitive Situation and Trends
2.7.1 Atrial Fibrillation Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atrial Fibrillation Devices Players Market Share by Revenue
2.7.3 Global Atrial Fibrillation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atrial Fibrillation Devices Retrospective Market Scenario by Region
3.1 Global Atrial Fibrillation Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atrial Fibrillation Devices Global Atrial Fibrillation Devices Sales by Region: 2019-2030
3.2.1 Global Atrial Fibrillation Devices Sales by Region: 2019-2024
3.2.2 Global Atrial Fibrillation Devices Sales by Region: 2025-2030
3.3 Global Atrial Fibrillation Devices Global Atrial Fibrillation Devices Revenue by Region: 2019-2030
3.3.1 Global Atrial Fibrillation Devices Revenue by Region: 2019-2024
3.3.2 Global Atrial Fibrillation Devices Revenue by Region: 2025-2030
3.4 North America Atrial Fibrillation Devices Market Facts & Figures by Country
3.4.1 North America Atrial Fibrillation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atrial Fibrillation Devices Sales by Country (2019-2030)
3.4.3 North America Atrial Fibrillation Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atrial Fibrillation Devices Market Facts & Figures by Country
3.5.1 Europe Atrial Fibrillation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atrial Fibrillation Devices Sales by Country (2019-2030)
3.5.3 Europe Atrial Fibrillation Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atrial Fibrillation Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Atrial Fibrillation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atrial Fibrillation Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Atrial Fibrillation Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atrial Fibrillation Devices Market Facts & Figures by Country
3.7.1 Latin America Atrial Fibrillation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atrial Fibrillation Devices Sales by Country (2019-2030)
3.7.3 Latin America Atrial Fibrillation Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atrial Fibrillation Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Atrial Fibrillation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atrial Fibrillation Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atrial Fibrillation Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Atrial Fibrillation Devices Sales by Type (2019-2030)
4.1.1 Global Atrial Fibrillation Devices Sales by Type (2019-2024)
4.1.2 Global Atrial Fibrillation Devices Sales by Type (2025-2030)
4.1.3 Global Atrial Fibrillation Devices Sales Market Share by Type (2019-2030)
4.2 Global Atrial Fibrillation Devices Revenue by Type (2019-2030)
4.2.1 Global Atrial Fibrillation Devices Revenue by Type (2019-2024)
4.2.2 Global Atrial Fibrillation Devices Revenue by Type (2025-2030)
4.2.3 Global Atrial Fibrillation Devices Revenue Market Share by Type (2019-2030)
4.3 Global Atrial Fibrillation Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atrial Fibrillation Devices Sales by Application (2019-2030)
5.1.1 Global Atrial Fibrillation Devices Sales by Application (2019-2024)
5.1.2 Global Atrial Fibrillation Devices Sales by Application (2025-2030)
5.1.3 Global Atrial Fibrillation Devices Sales Market Share by Application (2019-2030)
5.2 Global Atrial Fibrillation Devices Revenue by Application (2019-2030)
5.2.1 Global Atrial Fibrillation Devices Revenue by Application (2019-2024)
5.2.2 Global Atrial Fibrillation Devices Revenue by Application (2025-2030)
5.2.3 Global Atrial Fibrillation Devices Revenue Market Share by Application (2019-2030)
5.3 Global Atrial Fibrillation Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Atrial Fibrillation Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Atrial Fibrillation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Biosense Webster
6.3.1 Biosense Webster Corporation Information
6.3.2 Biosense Webster Description and Business Overview
6.3.3 Biosense Webster Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biosense Webster Atrial Fibrillation Devices Product Portfolio
6.3.5 Biosense Webster Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Atrial Fibrillation Devices Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Japan Lifeline
6.5.1 Japan Lifeline Corporation Information
6.5.2 Japan Lifeline Description and Business Overview
6.5.3 Japan Lifeline Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Japan Lifeline Atrial Fibrillation Devices Product Portfolio
6.5.5 Japan Lifeline Recent Developments/Updates
6.6 AtriCure
6.6.1 AtriCure Corporation Information
6.6.2 AtriCure Description and Business Overview
6.6.3 AtriCure Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AtriCure Atrial Fibrillation Devices Product Portfolio
6.6.5 AtriCure Recent Developments/Updates
6.7 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotronik Atrial Fibrillation Devices Product Portfolio
6.7.5 Biotronik Recent Developments/Updates
6.8 Philips
6.8.1 Philips Corporation Information
6.8.2 Philips Description and Business Overview
6.8.3 Philips Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Philips Atrial Fibrillation Devices Product Portfolio
6.8.5 Philips Recent Developments/Updates
6.9 Synaptic Medical
6.9.1 Synaptic Medical Corporation Information
6.9.2 Synaptic Medical Description and Business Overview
6.9.3 Synaptic Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Synaptic Medical Atrial Fibrillation Devices Product Portfolio
6.9.5 Synaptic Medical Recent Developments/Updates
6.10 Osypka AG
6.10.1 Osypka AG Corporation Information
6.10.2 Osypka AG Description and Business Overview
6.10.3 Osypka AG Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Osypka AG Atrial Fibrillation Devices Product Portfolio
6.10.5 Osypka AG Recent Developments/Updates
6.11 MicroPort Scientific
6.11.1 MicroPort Scientific Corporation Information
6.11.2 MicroPort Scientific Atrial Fibrillation Devices Description and Business Overview
6.11.3 MicroPort Scientific Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MicroPort Scientific Atrial Fibrillation Devices Product Portfolio
6.11.5 MicroPort Scientific Recent Developments/Updates
6.12 CardioFocus
6.12.1 CardioFocus Corporation Information
6.12.2 CardioFocus Atrial Fibrillation Devices Description and Business Overview
6.12.3 CardioFocus Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CardioFocus Atrial Fibrillation Devices Product Portfolio
6.12.5 CardioFocus Recent Developments/Updates
6.13 Lepu Medical
6.13.1 Lepu Medical Corporation Information
6.13.2 Lepu Medical Atrial Fibrillation Devices Description and Business Overview
6.13.3 Lepu Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lepu Medical Atrial Fibrillation Devices Product Portfolio
6.13.5 Lepu Medical Recent Developments/Updates
6.14 APT Med
6.14.1 APT Med Corporation Information
6.14.2 APT Med Atrial Fibrillation Devices Description and Business Overview
6.14.3 APT Med Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 APT Med Atrial Fibrillation Devices Product Portfolio
6.14.5 APT Med Recent Developments/Updates
6.15 TZ Medical
6.15.1 TZ Medical Corporation Information
6.15.2 TZ Medical Atrial Fibrillation Devices Description and Business Overview
6.15.3 TZ Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 TZ Medical Atrial Fibrillation Devices Product Portfolio
6.15.5 TZ Medical Recent Developments/Updates
6.16 Johnson & Johnson
6.16.1 Johnson & Johnson Corporation Information
6.16.2 Johnson & Johnson Atrial Fibrillation Devices Description and Business Overview
6.16.3 Johnson & Johnson Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Johnson & Johnson Atrial Fibrillation Devices Product Portfolio
6.16.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atrial Fibrillation Devices Industry Chain Analysis
7.2 Atrial Fibrillation Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atrial Fibrillation Devices Production Mode & Process
7.4 Atrial Fibrillation Devices Sales and Marketing
7.4.1 Atrial Fibrillation Devices Sales Channels
7.4.2 Atrial Fibrillation Devices Distributors
7.5 Atrial Fibrillation Devices Customers
8 Atrial Fibrillation Devices Market Dynamics
8.1 Atrial Fibrillation Devices Industry Trends
8.2 Atrial Fibrillation Devices Market Drivers
8.3 Atrial Fibrillation Devices Market Challenges
8.4 Atrial Fibrillation Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock